Fundamental Analysis
28 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -4.2% | -11.1% | 0 / 3 | +17.9% | -0.79 pp | -0.13 pp | +10.5% | 1.09 | 17.96 | 244 | +17,9% | 13,1 | +15,1% | 17.96 | 17.84 | +0,7% |
| Pts | 0 | 0 | 0 | 8 | 4 | 4 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 31.800 (close price on 2026-10-19)EPS (TTM): 1.771
Financial charts
1.Revenue & growth
VND bn244Q2/26
1.Revenue & growth
VND bn244Q2/26
2.Profit & growth
VND bn12,2Q2/26
3.Profit mix (Penman)
VND bn67,8Q2/26
4.Margins & cost structure
%30.3%Q2/26
5.Returns & cash cycle
% · days8.1%Q2/26
6.Earnings quality & cash
VND bn-2,94Q2/26
7.Asset structure
VND bn1.463Q2/26
8.Funding & debt health
VND bn · times1.463Q2/26
9.Revenue backlog
VND bn12,4Q2/26
10.Valuation
times · %21,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %342Q2/26
Adjusted EPS growth, latest quarter
-10.3%
Average adjusted EPS growth, 3 quarters
-8.9%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
20.1%
Source: vnstockData through Q2/26